GMED Globus Medical, Inc. Class A Common Stock

NYSE · Health Care · Visualizza su SEC EDGAR ↗
$87,29
Prezzo · Ago 18, 2026
Fondamentali al Ago 6, 2026

Informazioni su Globus Medical, Inc. Class A Common Stock Panoramica della società da Wikipedia

Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.

Leggi di più

Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.

Products

Globus develops, manufactures, and markets orthopedic implants including spine, trauma, and artificial joints.

Globus Medical makes the ExcelsiusGPS surgical robotic system for spine surgery. The robot is used for transpedicular drilling and screw placement. In November 2024, the company launched its ExcesiusHub, an advanced surgical navigation system for robotic surgical procedures.

The ADIRA XLIF Plate System aids in enhancing lateral spine surgery procedures.

Acquisitions

In January 2014, Globus Medical acquired Excelsius Surgical. The Excelsius system is designed to integrate intra-operative digital imaging with a robotic surgery device to hold patients in place during surgeries "with sub-millimeter accuracy". In October of that year, the company acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). TTOT provides human tissue products, including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.

In February 2015, Globus Medical acquired Branch Medical Group, a third-party manufacturer of high-precision medical devices.

In July 2016, Globus Medical acquired Alphatec Holdings, an international operations and distribution channel, for $80 million. As part of the transaction, Globus has agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.

In September 2018, Globus Medical acquired Nemaris, developers of Surgimap, a pre-operative planning software for spinal surgeons.

In August 2019, Globus Medical acquired privately owned StelKast, manufacturer of implants and instruments for hip and knee replacement.

In February 2023, Globus Medical acquired NuVasive in an all-stock deal valued at $3.1 billion.

Controversies

In August 2007 Globus Medical settled a lawsuit initially filed by Synthes in 2004 over alleged stolen trade secrets. Former Synthes employees, who then worked for Globus, were accused of stealing 2300 electronic files containing blueprints for Synthes' products, safety-testing plans, and verbatim 510(k) filing documents. Globus paid Synthes $13.5 million and did not admit any wrongdoing.

In 2011, Synthes filed a second lawsuit against Globus Medical for infringing three patents, "asking the court to force the defendant to destroy its allegedly infringing products." Orthopedic Design & Technology Magazine reports that, "There was no finding of willful infringement in this lawsuit." A $16 million monetary damage was paid by Globus Medical in 2013.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

GMED Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo
$87.28
Capitalizzazione di Mercato
P/E (TTM)
22.3
EPS (TTM)
$3.92
Ricavi (TTM)
$2.94B
Rendimento div.
ROE
12.1%
D/E Debito/Patrimonio
Intervallo 52 sett.
$54 – $101

GMED Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $2.94B
10-point trend, +421.1%
2016-12-31 2025-12-31
EPS $3.92
10-point trend, +263.0%
2016-12-31 2025-12-31
Flusso di cassa libero $589M
9-point trend, +349.5%
2016-12-31 2025-12-31
Margini 18.3%
7-point trend, -14.5%
2016-12-31 2023-12-31

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica
Tendenza 5 anni
GMED
Mediana dei peer
P/E (TTM)
5-point trend, -55.6%
22.3
27.5

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica
Tendenza 5 anni
GMED
Mediana dei peer
Operating Margin (Margine Operativo)
5-point trend, +15.7%
16.3%
Net Profit Margin (Margine di Profitto Netto)
5-point trend, +41.2%
18.3%
9.8%
ROA
5-point trend, +60.0%
10.2%
5.1%
ROE
5-point trend, +73.3%
12.1%
8.6%
ROIC
5-point trend, +55.2%
9.3%

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica
Tendenza 5 anni
GMED
Mediana dei peer
Current Ratio (Rapporto corrente)
5-point trend, -37.3%
4.3
2.7
Quick Ratio
5-point trend, +111.4%
2.5

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica
Tendenza 5 anni
GMED
Mediana dei peer
Revenue YoY (Ricavi YoY)
5-point trend, +206.7%
16.7%
Revenue CAGR 3Y (CAGR Ricavi 3Y)
5-point trend, +206.7%
42.2%
Revenue CAGR 5Y (CAGR Ricavi 5Y)
5-point trend, +206.7%
30.1%
EPS YoY
5-point trend, +172.2%
422.7%
Net Income YoY (Utile Netto YoY)
5-point trend, +260.5%
422.3%

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica
Tendenza 5 anni
GMED
Mediana dei peer
EPS (Diluted) (EPS (Diluito))
5-point trend, +172.2%
$3.92

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica
Tendenza 5 anni
GMED
Mediana dei peer

GMED Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 23 analisti
  • Acquisto forte 4 17,4%
  • Compra 12 52,2%
  • Mantieni 7 30,4%
  • Vendi 0 0,0%
  • Vendita forte 0 0,0%

Target Price a 12 Mesi

13 analisti · 2026-08-15
Target mediano $100.00 +14,6%
Target medio $103.23 +18,3%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media
0.15%
Periodo EPS Actual EPS Stimato Sorpresa
30 Giugno 2026 $1.34 $1.12 0.22%
31 Marzo 2026 $1.12 $0.94 0.18%
31 Dicembre 2025 $1.28 $1.17 0.11%
30 Settembre 2025 $1.18 $0.80 0.38%
30 Giugno 2025 $0.86 $0.77 0.09%
31 Marzo 2025 $0.68 $0.76 -0.08%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
GMED 22.3 16.7% 18.3% 12.1%
RMD $28.11B 18.7 9.8% 26.9% 23.6% 61.1%
ZBH $28.66B 25.3 7.2% 8.6% 5.6%
BAX $13.05B -10.2 5.7% -8.5% -14.6% 30.0%
PEN $12.20B 68.8 17.5% 12.7% 13.1% 67.1%
GKOS $6.49B -34.4 32.3% -37.0% -26.4% 55.7%
PODD $20.01B 81.7 30.7% 9.1% 16.6% 71.6%
TFX -6.0 17.2% -45.5% -24.6% 56.2%
NVST $3.56B 77.5 8.3% 1.7% 1.5% 54.7%
ITGR $2.69B 27.1 8.0% 5.5% 6.0% 27.0%
ABT $250.18B 33.7 5.7% 14.7% 13.1%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 16
Dati annuali Conto Economico per GMED
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +519.5% $2.94B $2.52B $1.57B $1.02B $958M $789M $785M $713M $636M $564M $545M $474M
Cost of Revenue 12-point trend, +764.7% $958M $1.04B $548M $264M $239M $217M $180M $159M $150M $135M $132M $111M
Gross Profit 10-point trend, +180.6% · · $1.02B $759M $719M $572M $605M $554M $486M $429M $412M $364M
R&D Expense 12-point trend, +372.5% $147M $164M $124M $73M $97M $85M $60M $55M $44M $45M $36M $31M
SG&A Expense 12-point trend, +524.8% $1.18B $981M $644M $432M $408M $355M $355M $312M $268M $222M $210M $189M
Operating Expenses 10-point trend, +293.9% · · $887M $531M $547M $460M $433M $384M $324M $275M $240M $225M
Operating Income 12-point trend, +246.8% $480M $166M $133M $228M $172M $111M $172M $169M $162M $154M $172M $138M
Other Non-op 12-point trend, +1118.9% $3M $2M $-2M $2M $8M $14M $18M $19M $8M $3M $583.0K $280.0K
Pretax Income 12-point trend, +336.4% $605M $121M $165M $243M $180M $126M $190M $189M $170M $157M $173M $139M
Income Tax 12-point trend, +45.6% $67M $18M $43M $53M $31M $24M $35M $32M $63M $53M $60M $46M
Net Income 12-point trend, +481.6% $538M $103M $123M $190M $149M $102M $155M $156M $107M $104M $113M $92M
EPS (Basic) 12-point trend, +306.1% $3.98 $0.76 $1.09 $1.89 $1.48 $1.04 $1.57 $1.60 $1.12 $1.09 $1.19 $0.98
EPS (Diluted) 12-point trend, +304.1% $3.92 $0.75 $1.07 $1.85 $1.44 $1.01 $1.52 $1.54 $1.10 $1.08 $1.17 $0.97
Shares (Basic) 12-point trend, +43.5% 135,215,000 135,726,000 113,087,000 100,469,000 100,734,000 98,580,000 99,150,000 97,884,000 96,243,000 95,647,000 95,046,000 94,227,000
Shares (Diluted) 12-point trend, +43.6% 137,056,000 137,863,000 114,630,000 102,643,000 103,623,000 100,971,000 101,998,000 101,316,000 97,887,000 96,432,000 96,073,000 95,457,000
EBITDA 11-point trend, +372.6% $757M $420M $278M · $242M $174M $225M $211M $204M $193M $196M $160M
Stato Patrimoniale 26
Dati annuali Stato Patrimoniale per GMED
Metrica Tendenza 202520242023202220212020201920182017201620152014
Cash & Equivalents 8-point trend, +539.6% $526M $784M · · · · $195M $140M $119M $67M $58M $82M
Short-term Investments 11-point trend, -78.8% $31M $106M $50M $296M $250M $187M · $200M $255M $223M $221M $146M
Receivables 12-point trend, +800.1% $679M $558M $503M $213M $164M $142M $154M $137M $117M $92M $78M $75M
Inventory 12-point trend, +734.9% $759M $659M $848M $299M $237M $229M $196M $131M $108M $113M $105M $91M
Prepaid Expense 12-point trend, +1039.4% $65M $50M $45M $21M $18M $18M $17M $15M $11M $15M $7M $6M
Current Assets 12-point trend, +352.2% $2.13B $2.18B $1.92B $983M $865M $822M $687M $631M $620M $514M $545M $470M
PP&E (Net) 12-point trend, +712.5% $564M $562M $587M $244M $221M $217M $200M $172M $143M $124M $115M $69M
PP&E (Gross) 12-point trend, +575.2% $1.27B $1.11B $1.01B $587M $527M $493M $444M $389M $335M $291M $254M $188M
Accum. Depreciation 12-point trend, +494.7% $705M $546M $426M $343M $306M $276M $244M $217M $192M $167M $139M $119M
Goodwill 12-point trend, +2597.6% $1.44B $1.43B $1.43B $197M $180M $157M $129M $124M $124M $106M $92M $53M
Intangibles 12-point trend, +2057.8% $745M $795M $925M $64M $69M $87M $79M $87M $79M $62M $33M $35M
Other Non-current Assets 12-point trend, +7980.1% $79M $75M $79M $37M $36M $32M $22M $10M $8M $928.0K $590.0K $975.0K
Total Assets 12-point trend, +653.7% $5.30B $5.25B $5.09B $2.08B $1.96B $1.68B $1.53B $1.30B $1.08B $928M $834M $704M
Accounts Payable 12-point trend, +521.6% $99M $75M $57M $36M $22M $18M $25M $26M $25M $17M $16M $16M
Accrued Liabilities 12-point trend, +442.4% $334M $261M $240M $92M $91M $78M $63M $60M $53M $46M $54M $61M
Current Liabilities 12-point trend, +457.5% $498M $856M $392M $159M $140M $121M $111M $96M $93M $80M $83M $89M
Capital Leases 7-point trend, +8999.6% $104M $84M $91M $3M $3M $3M $1M · · · · ·
Deferred Tax 11-point trend, +362.4% · $24M $84M $2M $4M $6M $6M $8M $11M $8M $13M $5M
Other Non-current Liabilities 12-point trend, +542.9% $21M $22M $25M $10M $13M $15M $9M $8M $2M $2M $2M $3M
Total Liabilities 12-point trend, +517.7% $730M $1.07B $1.09B $230M $216M $173M $130M $115M $111M $96M $119M $118M
Paid-in Capital 12-point trend, +1708.8% $3.17B $3.03B $2.87B $631M $554M $457M $357M $300M $238M $212M $193M $175M
Retained Earnings 12-point trend, +237.1% $1.39B $1.15B $1.14B $1.24B $1.19B $1.05B $1.05B $893M $736M $629M $525M $412M
AOCI 12-point trend, +1026.1% $15M $-7M $-10M $-25M $-7M $4M $-3M $-7M $-7M $-9M $-2M $-2M
Stockholders' Equity 12-point trend, +681.1% $4.57B $4.18B $4.00B $1.85B $1.74B $1.51B $1.40B $1.19B $968M $832M $715M $585M
Liabilities + Equity 12-point trend, +653.7% $5.30B $5.25B $5.09B $2.08B $1.96B $1.68B $1.53B $1.30B $1.08B $928M $834M $704M
Shares Outstanding 6-point trend, +5.4% · · · · · · 99,825,080 98,573,354 96,657,881 95,929,916 95,319,722 94,705,743
Flusso di cassa 16
Dati annuali Flusso di cassa per GMED
Metrica Tendenza 202520242023202220212020201920182017201620152014
D&A 12-point trend, +1172.6% $277M $253M $146M $68M $70M $63M $53M $42M $42M $39M $24M $22M
Stock-based Comp 12-point trend, +600.0% $50M $54M $53M $33M $31M $27M $26M $22M $15M $11M $10M $7M
Deferred Tax 11-point trend, -3234.3% · $-134M $-58M $-22M $-18M $-4M $4M $971.0K $8M $-4M $6M $-4M
Amort. of Intangibles 12-point trend, +16500.3% $118M $119M $51M $18M $19M $17M $14M $10M $8M $3M $2M $712.0K
Restructuring · $30M · · · · · · · · · ·
Other Non-cash 11-point trend, -191.0% $-111M $243M $-19M · $44M $11M $-66M $-39M $-13M $22M $-31M $-38M
Operating Cash Flow 12-point trend, +851.7% $753M $521M $243M $178M $276M $199M $172M $182M $159M $148M $124M $79M
CapEx 12-point trend, +565.3% $165M $115M $78M $74M $57M $64M $71M $60M $51M $41M $51M $25M
Investing Cash Flow 12-point trend, -255.0% $-355M $-176M $303M $-110M $-376M $-117M $-140M $-193M $-111M $-163M $-153M $-100M
Stock Issued · · · · · · · · · · · $10M
Stock Repurchased 5-point trend, +187.0% $300M $86M $226M $144M · $105M · · · · · ·
Net Stock Activity 5-point trend, -3185.3% $-300M $-86M $-226M · · $-105M · · · · · $10M
Financing Cash Flow 12-point trend, -5346.1% $-679M $-28M $-232M $-110M $54M $-39M $24M $33M $2M $470.0K $4M $13M
Net Change in Cash 12-point trend, -3255.6% $-258M $317M $317M $-43M $-46M $44M $56M $21M $51M $-16M $-25M $-8M
Taxes Paid 8-point trend, +223.8% $99M $159M $101M $78M $45M $25M $34M $31M · · · ·
Free Cash Flow 11-point trend, +981.9% $589M $405M $165M · $219M $135M $101M $122M $108M $131M $71M $54M
Redditività 8
Dati annuali Redditività per GMED
Metrica Tendenza 202520242023202220212020201920182017201620152014
Gross Margin 9-point trend, -15.1% · · 65.0% · 75.0% 72.4% 77.1% 77.6% 76.3% 76.1% 75.6% 76.6%
Operating Margin 11-point trend, -44.0% 16.3% 6.6% 8.5% · 17.9% 14.1% 21.9% 23.8% 25.4% 27.3% 31.6% 29.2%
Net Margin 11-point trend, -6.2% 18.3% 4.1% 7.8% · 15.6% 13.0% 19.8% 21.9% 16.9% 18.5% 20.7% 19.5%
Pretax Margin 11-point trend, -29.6% 20.6% 4.8% 10.5% · 18.8% 16.0% 24.2% 26.5% 26.7% 27.9% 31.7% 29.2%
EBITDA Margin 11-point trend, -23.7% 25.8% 16.7% 17.7% · 25.2% 22.1% 28.6% 29.6% 32.1% 34.2% 36.0% 33.8%
ROA 11-point trend, -30.1% 10.2% 2.0% 3.4% · 8.2% 6.4% 11.0% 13.2% 10.7% 11.8% 14.7% 14.6%
ROE 11-point trend, -30.6% 12.1% 2.5% 3.0% · 8.6% 7.0% 11.3% 13.5% 11.9% 13.5% 17.3% 17.5%
ROIC 11-point trend, -40.8% 9.3% 3.4% 2.5% · 8.2% 6.0% 10.0% 11.8% 10.6% 12.3% 15.7% 15.8%
Liquidità e Solvibilità 2
Dati annuali Liquidità e Solvibilità per GMED
Metrica Tendenza 202520242023202220212020201920182017201620152014
Current Ratio 11-point trend, -18.9% 4.3 2.5 4.9 · 6.2 6.8 6.2 6.6 6.7 6.4 6.6 5.3
Quick Ratio 11-point trend, -27.1% 2.5 0.8 1.4 · 3.0 1.2 3.1 5.0 5.3 4.8 4.3 3.4
Efficienza 3
Dati annuali Efficienza per GMED
Metrica Tendenza 202520242023202220212020201920182017201620152014
Asset Turnover 11-point trend, -25.5% 0.6 0.5 0.4 · 0.5 0.5 0.6 0.6 0.6 0.6 0.7 0.7
Inventory Turnover 11-point trend, -1.8% 1.4 1.4 1.0 · 1.0 1.0 1.1 1.3 1.4 1.2 1.4 1.4
Receivables Turnover 11-point trend, -30.9% 4.8 4.7 4.4 · 6.3 5.3 5.4 5.6 6.1 6.6 7.1 6.9
Per Azione 5
Dati annuali Per Azione per GMED
Metrica Tendenza 202520242023202220212020201920182017201620152014
Book Value / Share 6-point trend, +127.3% · · · · · · $14.05 $12.03 $10.01 $8.67 $7.50 $6.18
Revenue / Share 11-point trend, +331.5% $21.44 $18.27 $13.68 · $9.25 $7.81 $7.70 $7.04 $6.50 $5.85 $5.67 $4.97
Cash Flow / Share 11-point trend, +562.8% $5.50 $3.78 $2.12 · $2.67 $1.97 $1.69 $1.79 $1.63 $1.78 $1.27 $0.83
Cash / Share 6-point trend, +125.4% · · · · · · $1.96 $1.42 $1.23 $1.38 $0.63 $0.87
EPS (TTM) 12-point trend, +304.1% $3.92 $0.75 $1.07 $1.85 $1.44 $1.01 $1.52 $1.54 $1.10 $1.08 $1.17 $0.97
Tassi di Crescita 9
Dati annuali Tassi di Crescita per GMED
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -22.3% 16.7% 60.6% 53.3% 6.8% 21.4% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +63.8% 42.2% 38.0% 25.7% · · · · · · · · ·
Revenue CAGR 5Y 30.1% · · · · · · · · · · ·
EPS YoY 5-point trend, +892.9% 422.7% -29.9% -42.2% 28.5% 42.6% · · · · · · ·
EPS CAGR 3Y 3-point trend, +1366.0% 28.4% -19.5% 1.9% · · · · · · · · ·
EPS CAGR 5Y 31.2% · · · · · · · · · · ·
Net Income YoY 5-point trend, +820.8% 422.3% -16.2% -35.4% 27.5% 45.9% · · · · · · ·
Net Income CAGR 3Y 3-point trend, +557.5% 41.4% -11.6% 6.3% · · · · · · · · ·
Net Income CAGR 5Y 39.4% · · · · · · · · · · ·
Valutazione (TTM) 9
Dati annuali Valutazione (TTM) per GMED
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +519.5% $2.94B $2.52B $1.57B $1.02B $958M $789M $785M $713M $636M $564M $545M $474M
Net Income TTM 12-point trend, +481.6% $538M $103M $123M $190M $149M $102M $155M $156M $107M $104M $113M $92M
Market Cap 6-point trend, +161.1% · · · · · · $5.88B $4.27B $3.97B $2.38B $2.65B $2.25B
P/E 12-point trend, -9.1% 22.3 110.3 49.8 40.1 50.1 64.6 38.7 28.1 37.4 23.0 23.8 24.5
P/S 6-point trend, +57.7% · · · · · · 7.5 6.0 6.2 4.2 4.9 4.7
P/B 6-point trend, +9.0% · · · · · · 4.2 3.6 4.1 2.9 3.7 3.8
P / Cash Flow 6-point trend, +20.2% · · · · · · 34.2 23.5 24.9 13.8 21.7 28.4
P / FCF 6-point trend, +40.4% · · · · · · 58.1 35.0 36.7 18.2 37.2 41.4
Earnings Yield 12-point trend, +10.0% 4.5% 0.91% 2.0% 2.5% 2.0% 1.6% 2.6% 3.6% 2.7% 4.3% 4.2% 4.1%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ricavi $2.94B$2.52B$1.57B$1.02B$958M
Margine Lordo % 65.0%75.0%
Margine Operativo % 16.3%6.6%8.5%17.9%
Utile netto $538M$103M$123M$190M$149M
EPS Diluito $3.92$0.75$1.07$1.85$1.44
Stato Patrimoniale
2025-12-312024-12-312023-12-312022-12-312021-12-31
Rapporto corrente 4.32.54.96.2
Quick Ratio 2.50.81.43.0
Flusso di cassa
2025-12-312024-12-312023-12-312022-12-312021-12-31
Flusso di cassa libero $589M$405M$165M$219M

Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 642 filer · $5.7B totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente
Nuove posizioni Posizioni chiuse Aumentato Diminuito Variazione netta delle azioni
82 (-27 vs trimestre precedente) 80 (+30 vs trimestre precedente) 241 (+22 vs trimestre precedente) 176 (-6 vs trimestre precedente) +11.4M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione Valore Azioni % di 13F tracciati Tipo
VANGUARD CAPITAL MANAGEMENT LLC $403.546.103 5.107.532 7,04% Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC $394.606.359 4.994.385 6,89% Azioni
STATE STREET CORP $293.540.630 3.714.029 5,12% Azioni
Sculptor Capital LP $237.030.000 3.000.000 4,14% Azioni
Burgundy Asset Management Ltd. $212.054.428 3.460.983 3,70% Azioni
ALLIANCEBERNSTEIN L.P. $205.090.439 2.380.344 3,58% Azioni
DIMENSIONAL FUND ADVISORS LP $166.610.599 2.108.728 2,91% Azioni
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $135.630.225 1.716.621 2,37% Azioni
GEODE CAPITAL MANAGEMENT, LLC $134.690.079 1.704.191 2,35% Azioni
Boston Partners $112.054.767 1.418.394 1,96% Azioni
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC $101.519.633 1.284.896 1,77% Azioni
Quantinno Capital Management LP $96.320.933 1.219.098 1,68% Azioni
NORGES BANK $89.048.300 1.127.051 1,55% Azioni
FULLER & THALER ASSET MANAGEMENT, INC. $88.055.393 1.114.484 1,54% Azioni
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC $88.048.981 1.114.403 1,54% Azioni
MANUFACTURERS LIFE INSURANCE COMPANY, THE $84.736.329 1.072.476 1,48% Azioni
GENEVA CAPITAL MANAGEMENT LLC $78.941.870 999.138 1,38% Azioni
Madison Avenue Partners, LP $73.891.416 935.216 1,29% Azioni
Boston Trust Walden Corp $73.637.557 932.003 1,28% Azioni
ANTIPODES PARTNERS Ltd $71.581.796 905.984 1,25% Azioni
Global Alpha Capital Management Ltd. $67.681.230 856.616 1,18% Azioni
Vestal Point Capital, LP $67.158.500 850.000 1,17% Azioni
VANGUARD GROUP INC $59.221.500 678.290 1,03% Azioni
Stephens Investment Management Group LLC $57.159.864 723.451 1,00% Azioni
VANGUARD FIDUCIARY TRUST CO $56.575.822 716.059 0,99% Azioni
Clark Capital Management Group, Inc. $54.271.890 686.899 0,95% Azioni
AMERICAN CAPITAL MANAGEMENT INC $51.599.219 653.072 0,90% Azioni
ANCHOR CAPITAL ADVISORS LLC $51.225.201 648.338 0,89% Azioni
Camber Capital Management LP $47.216.000 800.000 0,82% Azioni
Capital World Investors $46.664.254 590.612 0,81% Azioni
Artemis Investment Management LLP $45.305.914 573.420 0,79% Azioni
Swedbank AB $41.113.881 520.363 0,72% Azioni
OBERWEIS ASSET MANAGEMENT INC/ $40.461.021 512.100 0,71% Azioni
RAYMOND JAMES FINANCIAL INC $39.194.096 496.065 0,68% Azioni
Paradice Investment Management LLC $39.023.513 493.906 0,68% Azioni
Soleus Capital Management, L.P. $37.049.527 468.922 0,65% Azioni
VICTORY CAPITAL MANAGEMENT INC $34.953.155 442.389 0,61% Azioni
ENVESTNET ASSET MANAGEMENT INC $34.559.104 437.402 0,60% Azioni
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ $33.569.453 424.876 0,59% Azioni
FIRST TRUST ADVISORS LP $32.942.568 416.943 0,57% Azioni
FMR LLC $32.503.608 411.386 0,57% Azioni
Grantham, Mayo, Van Otterloo & Co. LLC $32.370.792 409.705 0,56% Azioni
Holocene Advisors, LP $31.598.627 399.932 0,55% Azioni
Pembroke Management, LTD $31.513.929 398.860 0,55% Azioni
GOLDMAN SACHS GROUP INC $31.286.538 395.982 0,55% Azioni
Annex Advisory Services, LLC $30.189.344 350.387 0,53% Azioni
Bares Capital Management, Inc. $29.845.058 521.129 0,52% Azioni
Capital Impact Advisors, LLC $29.246.895 370.167 0,51% Azioni
SIRIOS CAPITAL MANAGEMENT L P $28.050.051 355.019 0,49% Azioni
Bridgewater Associates, LP $27.809.466 351.974 0,49% Azioni
CONGRESS ASSET MANAGEMENT CO $26.754.761 338.625 0,47% Azioni
Terril Brothers, Inc. $25.403.295 321.520 0,44% Azioni
Sio Capital Management, LLC $23.846.482 301.816 0,42% Azioni
SEGALL BRYANT & HAMILL, LLC $23.729.389 300.334 0,41% Azioni
Champlain Investment Partners, LLC $22.982.271 290.878 0,40% Azioni
RHUMBLINE ADVISERS $22.513.223 284.942 0,39% Azioni
Gotham Asset Management, LLC $22.364.413 283.058 0,39% Azioni
UBS Group AG $22.286.430 282.071 0,39% Azioni
KENNEDY CAPITAL MANAGEMENT LLC $22.020.640 278.707 0,38% Azioni
MetLife Investment Management, LLC $21.771.680 275.556 0,38% Azioni
Kathmere Capital Management, LLC $21.450.978 271.497 0,37% Azioni
Retirement Systems of Alabama $20.830.354 263.642 0,36% Azioni
Foresight Group Ltd Liability Partnership $19.759.724 254.030 0,34% Azioni
NICHOLAS COMPANY, INC. $19.699.484 249.329 0,34% Azioni
BANK OF AMERICA CORP /DE/ $19.524.872 247.119 0,34% Azioni
Varenne Capital Partners $18.807.009 238.200 0,33% Azioni
GLENMEDE TRUST CO NA $18.639.881 235.918 0,33% Azioni
Mesirow Institutional Investment Management, Inc. $18.549.041 224.266 0,32% Azioni
California Public Employees Retirement System $18.120.944 229.350 0,32% Azioni
Woodline Partners LP $17.906.826 226.640 0,31% Azioni
Swiss National Bank $17.862.344 226.077 0,31% Azioni
Corient Private Wealth LP $17.322.828 219.248 0,30% Azioni
GABELLI FUNDS LLC $16.671.110 211.000 0,29% Azioni
Lightrock Netherlands B.V. $16.367.000 207.151 0,29% Azioni
Sofinnova Investments, Inc. $15.802.000 200.000 0,28% Opzione Call
RENAISSANCE TECHNOLOGIES LLC $15.558.491 196.918 0,27% Azioni
STATE OF WISCONSIN INVESTMENT BOARD $15.455.225 195.611 0,27% Azioni
LPL Financial LLC $15.233.500 192.805 0,27% Azioni
Susquehanna Portfolio Strategies, LLC $15.165.574 191.945 0,26% Azioni
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $14.032.018 177.598 0,24% Azioni
Leith Wheeler Investment Counsel Ltd. $13.821.540 174.934 0,24% Azioni
BlackRock, Inc. $13.638.706 172.620 0,24% Azioni
AMERICAN CENTURY COMPANIES INC $13.486.770 170.697 0,24% Azioni
WCM INVESTMENT MANAGEMENT, LLC $13.455.918 160.304 0,23% Azioni
Leeward Investments, LLC - MA $12.983.476 164.327 0,23% Azioni
Walleye Capital LLC $12.358.823 156.421 0,22% Azioni
JANUS HENDERSON GROUP PLC $12.232.394 141.973 0,21% Azioni
Bellevue Group AG $11.543.993 146.108 0,20% Azioni
Sterling Investment Advisors, Ltd. $11.379.257 144.023 0,20% Azioni
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $11.223.202 130.260 0,20% Azioni
Defilade Capital Management, L.P. $11.032.719 139.637 0,19% Azioni
PARADIGM CAPITAL MANAGEMENT INC/NY $10.934.984 138.400 0,19% Azioni
Glenmede Investment Management, LP $10.909.935 190.500 0,19% Azioni
BNP PARIBAS FINANCIAL MARKETS $10.809.042 136.806 0,19% Azioni
ALGERT GLOBAL LLC $10.560.477 133.660 0,18% Azioni
GAMCO INVESTORS, INC. ET AL $10.209.435 129.217 0,18% Azioni
ArrowMark Colorado Holdings LLC $9.102.268 115.204 0,16% Azioni
STRS OHIO $8.815.936 111.580 0,15% Azioni
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. $8.503.609 107.627 0,15% Azioni
VANGUARD ASSET MANAGEMENT, Ltd $8.430.130 106.697 0,15% Azioni

Insider aziendali 22 insider · 11 dirigenti · 15 direttori

Insider Ruolo Ultima attività Azioni possedute Acquisti 12m Vendite 12m Netto 12m
Keith W Pfeil President, CEO 21 Gennaio 2026 A 0 0 0 $0
Daniel T Scavilla President, CEO 23 Gennaio 2025 A 0 0 0 $0
David M Demski President, CEO 27 Gennaio 2022 A 0 0 0 $0
Kyle Kline Senior Vice President, CFO 21 Gennaio 2026 A 0 0 2 $-2.032.133
Richard A Baron Senior VP and CFO 02 Maggio 2014 M 0 0 0 $0
Anthony L Williams President 07 Marzo 2019 M 0 0 0 $0
Kelly Huller EVP, GC, Corporate Secretary 25 Febbraio 2026 M 0 0 3 $-3.441.700
David C Paul Executive Chairman 21 Gennaio 2026 A 60.417 0 0 $0
Steven Payne Chief Accounting Officer 01 Febbraio 2019 A 0 0 0 $0
Eric Schwartz Senior VP and General Counsel 25 Giugno 2018 M 0 0 0 $0
Brett A Murphy EVP, International Sales 02 Febbraio 2018 A 35.217 0 0 $0
David D Davidar Direttore 27 Luglio 2026 G 507.675 0 2 $-4.169.000
Ann D Rhoads Direttore 04 Giugno 2026 M 40.384 0 3 $-1.402.600
Dan Wolterman Direttore 21 Gennaio 2026 A 24.025 0 0 $0
Leslie V Norwalk Direttore 21 Gennaio 2026 A 10.419 0 2 $-557.600
Dan Lemaitre Direttore 21 Gennaio 2026 A 0 0 0 $0
John A Deford Direttore 21 Gennaio 2026 A 15.578 0 0 $0
Robert Andrew Douglas Direttore 21 Gennaio 2026 A 2.005 0 0 $0
Stephen T Zarrilli Direttore 21 Gennaio 2026 A 0 0 1 $-2.107.250
James R Tobin Direttore 21 Gennaio 2026 A 0 0 0 $0
Kurt Wheeler Direttore 22 Gennaio 2019 A 44.319 0 0 $0
Robert Liptak Direttore 22 Gennaio 2019 A 26.159 0 0 $0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 99 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo Peso Unità Aggiornato al Fonte
FXH · First Trust Exchange-Traded AlphaDE… 2,27% 219.621 NS 30 Aprile 2026 N-PORT
GRPM · Invesco Exchange-Traded Fund Trust 1,93% 118.993 SH 08 Agosto 2026 Giornaliero
HTEC · EXCHANGE TRADED CONCEPTS TRUST 1,86% 10.979 NS 30 Aprile 2026 N-PORT
BUL · Pacer Funds Trust 1,53% 21.591 NS 30 Aprile 2026 N-PORT
IHI · iShares Trust 1,30% 536.949 SH 08 Agosto 2026 Giornaliero
LFSC · RBB Fund, Inc. 1,27% 16.258 NS 31 Maggio 2026 N-PORT
ROBO · EXCHANGE TRADED CONCEPTS TRUST 1,24% 242.837 NS 30 Aprile 2026 N-PORT
DTEC · ALPS ETF Trust 0,87% 7.891 NS 31 Maggio 2026 N-PORT
TAX · EA Series Trust 0,86% 2.682 NS 29 Maggio 2026 N-PORT
RFG · Invesco Exchange-Traded Fund Trust 0,86% 37.446 SH 08 Agosto 2026 Giornaliero
LSEQ · Harbor ETF Trust 0,83% 1.408 NS 30 Aprile 2026 N-PORT
MCOW · Pacer Funds Trust 0,82% 90 NS 30 Aprile 2026 N-PORT
FNY · First Trust Exchange-Traded AlphaDE… 0,55% 31.832 NS 30 Aprile 2026 N-PORT
TMFX · RBB Fund, Inc. 0,54% 2.130 NS 31 Maggio 2026 N-PORT
CZA · Invesco Exchange-Traded Fund Trust 0,51% 11.913 SH 08 Agosto 2026 Giornaliero
IJK · iShares Trust 0,49% 662.259 SH 08 Agosto 2026 Giornaliero
IVOG · VANGUARD ADMIRAL FUNDS 0,47% 111.810 SH 08 Agosto 2026 Giornaliero
MMSC · First Trust Exchange-Traded Fund VI… 0,39% 2.462 NS 31 Maggio 2026 N-PORT
JPME · J.P. Morgan Exchange-Traded Fund Tr… 0,38% 18.545 NS 30 Aprile 2026 N-PORT
GQQQ · EA Series Trust 0,34% 5.950 NS 29 Maggio 2026 N-PORT
BKMC · BNY Mellon ETF Trust 0,31% 21.679 NS 30 Aprile 2026 N-PORT
PTMC · Pacer Funds Trust 0,29% 12.781 NS 30 Aprile 2026 N-PORT
XJH · iShares Trust 0,29% 15.314 SH 08 Agosto 2026 Giornaliero
ISCG · iShares Trust 0,29% 35.610 SH 08 Agosto 2026 Giornaliero
FNX · First Trust Exchange-Traded AlphaDE… 0,29% 42.239 NS 30 Aprile 2026 N-PORT
SMDX · Tidal Trust III 0,29% 3.969 NS 30 Aprile 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,28% 26.195 NS 31 Maggio 2026 N-PORT
QVMM · Invesco Exchange-Traded Fund Trust … 0,28% 15.001 SH 08 Agosto 2026 Giornaliero
ANEW · ProShares Trust 0,26% 244 NS 31 Maggio 2026 N-PORT
IJH · iShares Trust 0,25% 3.909.873 SH 08 Agosto 2026 Giornaliero
IVOO · VANGUARD ADMIRAL FUNDS 0,25% 183.180 SH 08 Agosto 2026 Giornaliero
VBK · VANGUARD INDEX FUNDS 0,24% 1.499.816 SH 08 Agosto 2026 Giornaliero
CLSE · Trust for Professional Managers 0,23% 17.617 NS 31 Maggio 2026 N-PORT
BFOR · ALPS ETF Trust 0,22% 5.809 NS 31 Maggio 2026 N-PORT
FSMD · FIDELITY COVINGTON TRUST 0,21% 56.008 NS 30 Aprile 2026 N-PORT
BBMC · J.P. Morgan Exchange-Traded Fund Tr… 0,21% 46.648 NS 30 Aprile 2026 N-PORT
MIDU · Direxion Shares ETF Trust 0,20% 1.845 NS 30 Aprile 2026 N-PORT
MVV · ProShares Trust 0,20% 3.849 NS 31 Maggio 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,19% 535.955 NS 31 Maggio 2026 N-PORT
AFSM · First Trust Exchange-Traded Fund VI… 0,17% 2.091 NS 31 Maggio 2026 N-PORT
SCHM · SCHWAB STRATEGIC TRUST 0,17% 300.905 NS 31 Maggio 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0,16% 8.751 NS 30 Aprile 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0,16% 51.771 NS 30 Aprile 2026 N-PORT
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0,16% 7.980 NS 30 Aprile 2026 N-PORT
IYH · iShares Trust 0,15% 67.336 SH 08 Agosto 2026 Giornaliero
REVS · Columbia ETF Trust I 0,15% 4.563 NS 30 Aprile 2026 N-PORT
ISCB · iShares Trust 0,14% 5.059 SH 08 Agosto 2026 Giornaliero
UMDD · ProShares Trust 0,14% 538 NS 31 Maggio 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,13% 338.547 SH 08 Agosto 2026 Giornaliero
DFAS · Dimensional ETF Trust 0,13% 199.853 NS 30 Aprile 2026 N-PORT